Exact Mass: 263.030221
Exact Mass Matches: 263.030221
Found 41 metabolites which its exact mass value is equals to given mass value 263.030221
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-(5-chloro-2-methoxyphenyl)pyridine-3-carboxylic acid
2-(5-chloro-2-methoxyphenyl)pyridine-4-carboxylic acid
(2,5-Difluorophenyl)(3-nitrophenyl)methanone
C13H7F2NO3 (263.03939760000003)
METHYL 3-AMINO-4-(N-PROPYLSULFONYL)THIOPHENE-2-CARBOXYLATE
{[3-(Trifluoromethyl)benzyl]sulfonyl}acetonitrile
C10H8F3NO2S (263.02278240000004)
methyl 2-(2,5-dioxo-2H-pyrrol-1(5H)-ylthio)benzoate
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)THIOPHENE-2-CARBOXYLATE
2-(3-CHLORO-2,4,5-TRIFLUOROPHENYL)-4,5-DIHYDRO-4,4-DIMETHYLOXAZOLE
(4-Methoxy-3-nitrophenyl)-(thiophen-2-yl)methanone ,98
4-chloro-3-methoxy-6-phenylpyridine-2-carboxylic acid
Me2-APD
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
4-Chloro-N-(2-hydroxy-1,1-dimethylethyl)benzenesulfonamide
5-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-1,2,4-oxadiazole-3-car boxamide
2-chloro-6-phenylmethoxypyridine-4-carboxylic acid
4-(4-CHLOROPHENYLSULFANYL)PIPERIDINE HYDROCHLORIDE
2-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-1,3-THIAZOLE-4-CARBOXYLIC ACID
3-[(3-methoxyphenyl)sulfonyl]azetidine hydrochloride
L-701252
L-701252 is a potent antagonist of glycine site NMDA receptor with an IC50 of 420 nM. L-701252 provides a small degree of neuroprotection in global cerebral ischaemia[1].
3-(4-NITRO-1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID
merbarone
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors
Nitrososulfapyridine
A pyridine having a 4-nitrosobenzenesulfonamido group at the 2-position.